Unlocking the mysteries of childhood disease through innovative, collaborative scientific inquiry.
CHINJ scientists perform basic, translational and population-based research in four major disease areas. Our research is highly collaborative and scientists routinely work across different focus areas to facilitate discovery and applications to children’s health.
Researchers discover fundamental mechanisms in the body’s immune and inflammatory mechanisms and with physician-scientists to investigate major childhood diseases such as asthma, type 1 diabetes, inflammatory bowel disease, other autoimmune disorders, childhood infections, and vaccine optimization.
Institute investigators are working with scientists at Rutgers Cancer Institute of New Jersey to understand how pediatric cancers, including leukemia, arise from mutated tissue stem cells. They are also studying how induced and adult stem cells may be used to create patient-derived models of brain and developmental disorders, and provide new tools for regenerative and reparative medicine.
World-leading neuroscientists work with colleagues across Robert Wood Johnson Medical School, the Brain Health Institute and Rutgers pediatricians, to study the causes and treatments of autism and other neurodevelopmental disorders, such as congenital muscular dystrophies. Researchers also study abnormalities of nerve cell function in neuropsychiatric disease such as schizophrenia and the molecular basis of addictions.
In collaboration with pediatricians and scientists at the Rutgers Robert Wood Johnson Medical School and across Rutgers, Institute investigators are studying the neurological, genetic, environmental, and inflammatory causes of childhood obesity and its consequences. Researchers also study the origins and mechanisms and novel therapies for type 1- and type 2-diabetes, and study genetic controls of child growth and development.
CHINJ scientists have both research and clinical expertise, and their work explores a broad range of topics in child health.
A Rutgers study suggests the underproduction of poorly understood immune cells contribute to Alzheimer’s disease and other forms of cognitive decline.
Rutgers-led study highlights potential of new techniques to study mental disorders.
Rutgers researchers have been awarded $1.6 million from the National Institutes of Health for the study.
Collaborate with CHINJ scientists, clinicians, and staff across Rutgers University and affiliate hospitals to innovate and make medical breakthroughs in critical areas of child health.